Skip to main content

Articles

ASH 2019 - Chronic Lymphocytic Leukemia
Combined Ibrutinib and Venetoclax for First-Line Treatment of Patients with Chronic Lymphocytic Leukemia
Read More
ASH 2019 - Chronic Lymphocytic Leukemia
ELEVATE TN: Results of a Phase 3 Study of Acalabrutinib in Patients with Treatment-Naïve Chronic Lymphocytic Leukemia
Read More
ASH 2019 - Chronic Lymphocytic Leukemia
Ibrutinib + Venetoclax for First-Line Treatment of CLL: Results from the MRD Cohort of the Phase 2 CAPTIVATE Study
Read More
ASH 2019 - Chronic Lymphocytic Leukemia
Polatuzumab Vedotin + Obinutuzumab + Lenalidomide in Patients with Relapsed/Refractory Follicular Lymphoma
Read More
FDA Approvals, In the News
November 11, 2019 — Oncology News & Updates
Read More
In the News, Leukemia, Oncology
November 4, 2019 — Oncology News & Updates
Read More
FDA Approvals, In the News
October 28, 2019 – Oncology News & Updates
Read More
Breast Cancer, FDA Approvals, In the News, Multiple Myeloma, Pediatric Cancer, Oncology
Vincristine, Racial Disparities in Multiple Myeloma, and HER2 Metastatic Breast Cancer Are in the News
Read More
Original Research, Practice Management
Differences in Patient Demographics and Healthcare Costs of Patients with PIDD Receiving Intravenous or Subcutaneous Immunoglobulin Therapies in the United States
Michael C. Runken, PharmD; Joshua M. Noone, PhD; Christopher M. Blanchette, PhD, MBA; Emily Zacherle, MS; Reuben Howden, PhD
Stakeholder Perspective
Shared Decision-Making and Payer Preferences: IVIG or SCIG Route of Administration?
Gary M. Owens, MD
Read More
Original Research, Practice Management
Costs and Healthcare Resource Utilization Associated with Hospital Admissions of Patients with Metastatic or Nonmetastatic Prostate Cancer
Krishna Tangirala, MPH; Sreevalsa Appukkuttan, MPH, MBBS; Stacey Simmons, MD
Read More
Page 44 of 244
Results 431 - 440 of 2434